GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Catalyst Pharmaceuticals Inc (FRA:CN2) » Definitions » Inventories, Raw Materials & Components

Catalyst Pharmaceuticals (FRA:CN2) Inventories, Raw Materials & Components : €6.3 Mil (As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Catalyst Pharmaceuticals Inventories, Raw Materials & Components?

Catalyst Pharmaceuticals's inventories, raw materials & components for the quarter that ended in Sep. 2024 was €6.3 Mil.

Catalyst Pharmaceuticals's quarterly raw materials declined from Mar. 2024 (€5.5 Mil) to Jun. 2024 (€5.2 Mil) but then increased from Jun. 2024 (€5.2 Mil) to Sep. 2024 (€6.3 Mil).

Catalyst Pharmaceuticals's annual raw materials declined from Dec. 2021 (€1.6 Mil) to Dec. 2022 (€0.0 Mil) but then increased from Dec. 2022 (€0.0 Mil) to Dec. 2023 (€1.8 Mil).


Catalyst Pharmaceuticals Inventories, Raw Materials & Components Historical Data

The historical data trend for Catalyst Pharmaceuticals's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Catalyst Pharmaceuticals Inventories, Raw Materials & Components Chart

Catalyst Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.57 - 1.75

Catalyst Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 1.75 5.45 5.20 6.26

Catalyst Pharmaceuticals Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Catalyst Pharmaceuticals Business Description

Industry
Traded in Other Exchanges
Address
355 Alhambra Circle, Suite 801, Coral Gables, FL, USA, 33134
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

Catalyst Pharmaceuticals Headlines

No Headlines